Receptor tyrosine kinases are signaling intermediates of G protein-coupled receptors

被引:36
作者
Piiper, A [1 ]
Zeuzem, S [1 ]
机构
[1] Univ Saarland, Dept Internal Med 2, D-66421 Homburg, Germany
关键词
Transactivation; MAP kinases; cell survival; EGF receptor; PDGF receptor; Trk; Akt;
D O I
10.2174/1381612043382936
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors (GPCRs) can utilize receptor tyrosine kinases (RTKs) to mediate important cellular responses such as proliferation, differentiation and survival. Recent advances in the field suggest that GPCR-induced transactivation of RTKs might be important for diseases such as cancer and cardiac hypertrophy. Depending on the receptor and cell type, GPCR signaling involves activation of several different RTKs. By activating different subsets of RTKs, GPCRs can fine-tune their effects on target cells. Furthermore, RTK-independent signaling pathways also initiated by GPCRs may modify the biological read out of the transactivated RTKs. This review focuses on the mechanisms how GPCRs and intracellular messengers elicit transactivation of different RTKs and the resulting different biological responses.
引用
收藏
页码:3539 / 3545
页数:7
相关论文
共 79 条
[1]  
Adomeit A, 1999, MOL CELL BIOL, V19, P5289
[2]   Tethering of the platelet-derived growth factor ß receptor to G-protein-coupled receptors -: A novel platform for integrative signaling by these receptor classes in mammalian cells [J].
Alderton, F ;
Rakhit, S ;
Kong, KC ;
Palmer, T ;
Sambi, B ;
Pyne, S ;
Pyne, NJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :28578-28585
[3]   Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade [J].
Andreev, J ;
Galisteo, ML ;
Kranenburg, O ;
Logan, SK ;
Chiu, ES ;
Okigaki, M ;
Cary, LA ;
Moolenaar, WH ;
Schlessinger, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20130-20135
[4]   Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy [J].
Asakura, M ;
Kitakaze, M ;
Takashima, S ;
Liao, Y ;
Ishikura, F ;
Yoshinaka, T ;
Ohmoto, H ;
Node, K ;
Yoshino, K ;
Ishiguro, H ;
Asanuma, H ;
Sanada, S ;
Matsumura, Y ;
Takeda, H ;
Beppu, S ;
Tada, M ;
Hori, M ;
Higashiyama, S .
NATURE MEDICINE, 2002, 8 (01) :35-40
[5]   Epidermal growth factor (EGF)-induced generation of hydrogen peroxide - Role in EGF receptor-mediated tyrosine phosphorylation [J].
Bae, YS ;
Kang, SW ;
Seo, MS ;
Baines, IC ;
Tekle, E ;
Chock, PB ;
Rhee, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (01) :217-221
[6]   The fibroblast growth factor receptor is at the site of convergence between μ-opioid receptor and growth factor signaling pathways in rat C6 glioma cells [J].
Belcheva, MM ;
Haas, PD ;
Tan, Y ;
Heaton, VM ;
Coscia, CJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :909-918
[7]   PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor [J].
Bergsten, E ;
Uutela, M ;
Li, XR ;
Pietras, K ;
Östman, A ;
Heldin, CH ;
Alitalo, K ;
Eriksson, U .
NATURE CELL BIOLOGY, 2001, 3 (05) :512-516
[8]   Gs protein-coupled receptor agonists induce transactivation of the epidermal growth factor receptor in T84 cells -: Implications for epithelial secretory responses [J].
Bertelsen, LS ;
Barrett, KE ;
Keely, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (08) :6271-6279
[9]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[10]   c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function [J].
Biscardi, JS ;
Maa, MC ;
Tice, DA ;
Cox, ME ;
Leu, TH ;
Parsons, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :8335-8343